Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Effective control of plaque psoriasis achieved with continuous efalizumab

Dec. 3, 2003

Etanercept monotherapy for plaque psoriasis

Dec. 2, 2003

Pilot study of SWT-01.100 supports mode of action for treatment of psoriasis

Nov. 27, 2003

Allergan submits NDA for oral tazarotene for psoriasis

Nov. 27, 2003

Xantryl advances for psoriasis

Nov. 25, 2003

MBI-594AN shows efficacy in phase IIb acne study

Nov. 19, 2003

New Zealand phase II trial for AVAC in pediatric atopic dermatitis

Nov. 19, 2003

Access files OraDisc A NDA

Nov. 19, 2003

EpiTan plans IND filing for Melanotan

Nov. 13, 2003

Clinical benefits of efalizumab in plaque-type psoriasis

Nov. 10, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...